Status:
WITHDRAWN
Hair Transplantation for Treatment of Vitiligo
Lead Sponsor:
Mehdi Rashighi
Conditions:
Vitiligo
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
There are several surgical methods to treat vitiligo patches, and follicular unit extraction (FUE) is one among them. FUE, performed using punch biopsy extraction and hair follicle transplantation, ha...
Detailed Description
Vitiligo is an autoimmune skin condition that can have a profound psychosocial impact on patients. Vitiligo is caused by an immune-mediated destruction of melanocytes, or the cells responsible for pro...
Eligibility Criteria
Inclusion
- Adults 18 years and older
- Vitiligo patients already on treatment who demonstrate stable disease (have noted some repigmentation in hair bearing areas)
- Willingness to participate in the study
- Willingness to undergo biopsies of full-thickness skin tissue from areas without vitiligo and having them transplanted into areas with vitiligo
- Informed consent agreement signed by the subject
Exclusion
- Adults unable to consent (adults lacking capacity)
- Individuals who are not yet adults (infants, children, teenagers)
- Pregnant women
- Prisoners
- Unable to return for follow-up visits
- Infection or other dermatologic condition different than vitiligo in the area to be treated
- Personal or family history of keloid formation
- Known allergies to injectable lidocaine or other topical anesthetics
- Systemic immunosuppressive medication (oral corticosteroids) within prior 4 weeks
- Topical steroids at planned recipient site within the prior 1 week
- Individuals who are unwilling to discontinue topical steroids at recipient site
- Prescription or over-the-counter medication or cosmetics containing: retinoids, glycolic acid, salicylic acid, topical steroids at the site of treatment or oral corticosteroids, or any other remedies that might affect the healing process. Non-medicated moisturizers are allowed.
- Co-existent inflammatory skin disease
- Any other condition or laboratory value that would, in the professional opinion of the investigators, potentially affect the subject's response or the integrity of the data or would pose an unacceptable risk to the subject.
Key Trial Info
Start Date :
August 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 15 2023
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04858152
Start Date
August 1 2021
End Date
August 15 2023
Last Update
May 24 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Massachusetts Medical School
Worcester, Massachusetts, United States, 01605